Table 2. Patient charges . All patients... | American Society of Hematology

Table 2.

Patient charges

	All patients	Patients not receiving deferoxamine	Patients receiving deferoxamine
Total UB-92 charges	359 592 (53)^*	110 570 (91)^*	249 022 (45)^*
UB-92-300 (lab)	208 180 (58)^†	61 917 (56)^†	146 263 (59)^†
UB-92-391 (transfusion)	56 311 (16)^†	8 213 (7)^†	48 098 (19)^†
UB-92-other	95 101 (26)^†	40 440 (37)^†	54 661 (22)^†
Chelation charges	287 202 (42)^*	—	287 202 (51)^*
Physician fees	31 765 (5)^*	11 078 (9)^†	20 687 (4)^*
Total charges	678 559	121 648	556 911

	All patients	Patients not receiving deferoxamine	Patients receiving deferoxamine
Total UB-92 charges	359 592 (53)^*	110 570 (91)^*	249 022 (45)^*
UB-92-300 (lab)	208 180 (58)^†	61 917 (56)^†	146 263 (59)^†
UB-92-391 (transfusion)	56 311 (16)^†	8 213 (7)^†	48 098 (19)^†
UB-92-other	95 101 (26)^†	40 440 (37)^†	54 661 (22)^†
Chelation charges	287 202 (42)^*	—	287 202 (51)^*
Physician fees	31 765 (5)^*	11 078 (9)^†	20 687 (4)^*
Total charges	678 559	121 648	556 911

Data represent 1997-1998 U.S. dollars (%).

Percentage of total charges.

Percentage of UB-92 charges.